RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
Quick Stats
Jan 30, 202659.3
AI Score
HOLD1.11
Volume Ratio
Mar 05, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
RAPT Stock Summary
Last updated Jan 30, 2026
RAPT is currently trading at $57.68, positioned above its 200-day moving average of $19.5, indicating a long-term uptrend. The stock has a 52-week range of $0.836 to $57.8.
Technical Analysis: The 50-day moving average stands at $37.51, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 80.272, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.177, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RAPT at 59.3/100 with a HOLD recommendation.
RAPT (RAPT Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 80.272 |
| CMF (20) | 0.177 |
| ROC (10) | 79.186 |
| ADX (14) | 41.622 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 6.82 |
| AROONOSC (14) | 64.286 |
| WILLAMS %R (14) | -0.465 |
| MFI (14) | 78.821 |
RAPT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RAPT Price vs Max Options Open Interest
RAPT Max Change In Options Open Interest
RAPT Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RAPT Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RAPT Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RAPT Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RAPT Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
RAPT Moving Averages Analysis
RAPT Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
RAPT Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
RAPT (RAPT Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 55.37 |
| 20 | 43.94 |
| 30 | 40.91 |
| 50 | 37.51 |
| 100 | 31.23 |
| 200 | 19.5 |
RAPT Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.7 billion |
| Earnings/Share ($) | -11.66 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.475 |
| EPS Estimate Next Year ($) | -3.105 |
| WallStreet Target Price ($) | 58 |
| Most Recent Quarter |